This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
49
0.5% concentration of Topical oxygen
0.25% concentration topical oxygen
no O2
Dermatology Consultants Inc
High Point, North Carolina, United States
skin grading evaluation of photodamage
Time frame: 8 weeks
stratum corneum hydration (skin capacitance)
Time frame: 8 weeks
bioinstrumental assessment of skin "melanin" lightening, and lesional erythematous sites
Time frame: 8 weeks
bioinstrumental assessment of skin texture, scaliness (desquamation)
Time frame: 8 weeks
punch biopsy histopathologic examination (H&E, and immunohistochemistry for Aquaporin 3, and Filaggrin)
Time frame: 8 weeks
RT-PCR collagenase , and hypoxia-inducible factor-1 alpha
Time frame: 8 weeks
product performance
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.